A $225 billion treatment market is badly in need of new therapies. Here is the roadmap for investors to capitalize on this opportunity.
Functional Mushrooms: The Psychedelics Stepping Stone
Functional mushrooms are a large-and-growing health supplements market with synergies to psychedelics operations.
TSI EDITOR |
2020-09-17
Is Psilocybin More Revolutionary Than Spravato for Depression?
Spravato has not been the "game-changer" for treating depression that it was touted as being. The market remains wide open for psilocybin (and other psychedelics).
TSI EDITOR |
2020-09-14
ATAI Positioned As Kingmaker In Psychedelics Space
ATAI Life Sciences is looking more and more like the driving force in the psychedelic drug industry.
TSI EDITOR |
2020-09-09
Who is Mind Cure Health?
A new functional-and-psychedelic mushroom company is preparing to go public.
TSI EDITOR |
2020-09-01
Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.
TSI EDITOR |
2020-08-31
Psychedelic Drugs Go Mainstream
As the Renaissance for psychedelic drugs progresses, we see these substances acquiring mainstream status in various ways.
TSI EDITOR |
2020-08-27
Why Are Silicon Valley AND Wall Street Backing Psychedelic Drugs?
Wall Street and Silicon Valley investors recently piled into a $30-million psychedelics fund-raising initiative.
TSI EDITOR |
2020-08-24
ATAI Life Sciences Forges Premier Psychedelics R&D Platform
ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.
TSI EDITOR |
2020-06-19
Psychedelic Drugs: Powerful Medicine, Life-Changing Results
Psychedelic drug therapies continue to win over new supporters. But the clock is ticking with our Mental Health Crisis...
TSI EDITOR |
2020-08-18
Latest Stories
NEW BULL MARKET ALERT
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now